The relationship between intervention in the CD40 signal pathway and choroidal neovascularization

OncoTargets and Therapy

Volumn 7, Issue , 2014, Pages 263-267

  Zhang, Peipei ^a,b   Su, Yan ^a,b   Liu, Fang ^a,b  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis factor; CD40; Choroidal neovascularization; NV

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; MEMBRANE ANTIGEN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; B LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; LOW LEVEL LASER THERAPY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84896730098     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S56909     Document Type: Review

References (33)

1. Tsutsumi C, Sonoda KH, Egashira K, et al. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol. 2003;74(1):25-32.
2. Skeie JM, Mullins RF. Elastin-mediated choroidal endothelial cell migration: possible role in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49(12):5574-5580.
3. Reinders ME, Sho M, Robertson SW, et al. Proangiogenic function of CD40 ligand-CD40 interactions. J Immunol. 2003;171(3):1534-1541.
4. Phipps RP. Atheroscleros: the emerging role of inflammation and the role CD40-CD40 ligand system. Proc Natl Acad Sci U S A. 2000;97(13): 6930-6932.
5. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood. 1990;76(12):2449-2456.
6. Flaxenburg JA, Melter M, Lapchak PH, Briscoe DM, Pal S. The CD40-induced signaling pathway in endothelial cells resulting in the overexpression of vascular endothelial growth factor involves Ras and phosphatidylinositol 3-kinase. J Immunol. 2004;172(12):7503-7509.
7. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: requirement of B7-D28 signaling through CD40. Science. 1996;273(5283):1862-1864.
8. Li Qiu, Yang Xiqiang. CD40/CD40L inflammatory reaction in the role of interleukin.1. Chinese Journal of Pediatrics. 1999;37(2):123-125.
9. Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS. 1997;79:233-269.
10. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249-257.
11. Xie F, Shi Q, Wang Q, et al. CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma. J Neuroimmunol. 2010;222(1-2):62-69.
12. Chakrabarti S, Rizvi M, Morin K, et al. The role of CD40L and VEGF in the modulation of angiogenesis and inflammation. Vascul Pharmacol. 2010;5(3-4):130-137.
13. Sidky YA, Auerbach R. Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs-host reaction. J Exp Med. 1975;141(5):1084-1100.
14. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977;269(5631): 804-806.
15. Auerbach R, Sidky YA. Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol. 1979;123(2):751-754.
16. Moulton KS, Melder RJ, Dharnidharka VR, Hardin-Young J, Jain RK, Briscoe DM. Angiogenesis in the huPBL-SCID model of human transplant rejection. Transplantation. 1999;67(12):1626-1631.
17. Koch AE, Polverini PJ, Leibovich SJ. Induction of neovascularization by activated human monocytes. J Leukoc Biol. 1986;39(2): 233-238.
18. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun. 1988;157(2):793-800.
19. Karimi MH, Pourfathollah AA. CD40 and tolerance induction. Iran J Allergy Asthma Immunol. 2012;11(1):1-13.
20. Kawabe T, Matsushima M, Hashimoto N, Imaizumi K, Hasegawa Y. CD40/CD40 ligand interactions in immune responses and pulmonary immunity. Nagoya J Med Sci. 2011;73(3-4):69-78.
21. Dormond O, Contreras AG, Meijer E, et al. CD40-induced signaling in human endothelial cells results in mTORC2- and Akt-dependent expression of vascular endothelial growth factor in vitro and in vivo.1. J Immunol. 2008;181(11):8088-8095.
22. Hoerster R, Muether PS, Vierkotten S, Schröder S, Kirchhof B, Fauser S. In-vivo and ex-vivo characterization of laser-induced choroidal neovascularization variability in mice. Graefes Arch Clin Exp Ophthalmol. 2012;250(11):1579-1586.
23. Grossniklaus HE, Ling JX, Wallace TM, et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol Vis. 2002;8:119-126.
24. Shi YY, Wang YS, Zhang ZX, et al. Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells. Graefes Arch Clin Exp Ophthalmol. 2011;249(11):1667-1679.
25. Huang H, Parlier R, Shen JK, Lutty GA, Vinores SA. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PloS One. 2013;8(8):e71808.
26. Zhao H, Roychoudhury J, Doggett TA, Apte RS, Ferguson TA. Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013;54(8):5321-5331.
27. Portillo JA, Van Grol J, Zheng L, et al. CD40 mediates retinal inflammation and neurovascular degeneration. J Immunol. 2008;181(12):8719-8726.
28. Grisanti S, Ishioka M, Kosiewicz M, Jiang LQ. Immunity and immuneprivilege elicited by cultured retinal pigment epithelial celltransplant. Invest Ophthalmol Vis Sci. 1997;38(8):1619-1626.
29. Willermain F, Caspers-Velu L, Baudson N, et al. Role and expression of CD40 on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2000;41(11):3485-3491.
30. Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999;117(3): 329-339.
31. Ishida K, Panjwani N, Cao Z, Streilein JW. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflam. 2003;11(2):91-105.
32. Sugita S, Horie S, Yamada Y, Mochizuki M. Inhibition of B cell activation by retina pigment epithelium. Invest Ophthalml Vis Sci. 2010;51(11):5783-5788.
33. Kelley SK, Gelzleichter T, Xie D, et al. Preclinical pharma cokinetics pharmacodynamics, and acitivity of a humanized anti-CD40 antibody (SGN40) in rodents and non-human primates. Cancer Res. 2006;148(8): 1116-1123.